Health School, Polytechnic Institute of Porto, Porto, Portugal, Rua Dr. António Bernardino de Almeida, 400 Box: 4200-072, Porto. Portugal.
Polytechnic Institute of Porto, Health School, Porto. Portugal.
CNS Neurol Disord Drug Targets. 2017;16(6):638-651. doi: 10.2174/1871527315666161223142918.
Cognitive impairment is a major manifestation of schizophrenia and a crucial treatment target as these deficits are closely related to patients' functional outcomes. Cognitive remediation is the gold-standard practice to address cognitive deficits in schizophrenia. There is clear evidence stating that cognitive remediation improves cognitive function and promotes structural neuroplastic changes in patients with schizophrenia, with brain-derived neurotrophic factor (BDNF) expression emerging as a potential biomarker for its efficacy. This is particularly important as there is clear evidence relating atypical BDNF expression to cognitive impairment in patients with schizophrenia. Despite the valuable role of cognitive remediation in the management of schizophrenia, there is still a need to develop methods that allow maximizing its efficacy.
In this review, we present a hypothesis arguing that cognitive remediation efficacy for patients with schizophrenia can be enhanced by aerobic exercise-induced BDNF upregulation. There have been a few trials reporting that combining aerobic exercise with cognitive training was superior to cognitive training alone to improve cognitive functioning in patients with schizophrenia. Furthermore, there is preliminary evidence suggesting that combined aerobic and cognitive training can increase peripheral BDNF levels.
Thereby, engaging in aerobic exercise in close temporal proximity to cognitive remediation may allow achieving a state of neuroplastic readiness in the brain, facilitating cognitive functioning enhancement. Although this hypothesis still lacks evidence, future clinical trials using cognitive remediation for schizophrenia should explore strategies to maximize neuroplasticity and achieve optimal cognitive improvements.
认知障碍是精神分裂症的主要表现之一,也是一个重要的治疗靶点,因为这些缺陷与患者的功能结果密切相关。认知矫正被认为是解决精神分裂症认知缺陷的金标准方法。有明确的证据表明,认知矫正可以改善精神分裂症患者的认知功能,并促进其结构神经可塑性变化,脑源性神经营养因子(BDNF)的表达被认为是其疗效的一个潜在生物标志物。这一点尤为重要,因为有明确的证据表明,非典型 BDNF 的表达与精神分裂症患者的认知障碍有关。尽管认知矫正在精神分裂症的治疗中具有重要作用,但仍需要开发方法来最大限度地提高其疗效。
在这篇综述中,我们提出了一个假设,即有氧运动诱导的 BDNF 上调可以增强认知矫正对精神分裂症患者的疗效。有几项试验报告称,将有氧运动与认知训练相结合比单纯的认知训练更能改善精神分裂症患者的认知功能。此外,初步证据表明,联合有氧和认知训练可以增加外周 BDNF 水平。
因此,在进行认知矫正的同时进行有氧运动,可以使大脑达到神经可塑性准备状态,从而促进认知功能的增强。尽管这一假设仍缺乏证据,但未来使用认知矫正治疗精神分裂症的临床试验应探索最大限度地提高神经可塑性和实现最佳认知改善的策略。